Global Marburg Hemorrhagic Fever Drug Market by Types (Marburg Vaccine, AVI-7288, TKM-Marburg, and Others) Application (Clinics, Hospitals, Others), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa), Forecasts, 2021-2028
The global Marburg hemorrhagic fever drug market is anticipated to expand at substantial CAGR during the forecast period, between 2021 and 2028. Marburg virus causes Marburg viral disease (MVD), which has a case fatality rate of up to 88% but can be reduced significantly with proper patient care. Marburg virus was first discovered in 1967, following simultaneous epidemic in Marburg and Frankfurt, as well as Belgrade, Serbia. The Filoviridae family includes Marburg and Ebola viruses (filovirus). The two diseases are clinically identical, despite the fact that they are caused by distinct viruses. Both illnesses are uncommon, but they have the potential to generate large-scale epidemics with substantial death rates.
Market Trends, Drivers, Restraints, and Opportunities:
- Increased research and developments made in the vaccine production is expected to drive the growth for the market over forecast period.
- Rise in prevalence of chronic diseases around the world and increasing awareness about disease treatment are expected to raise the growth for the market.
- High cost associated with the treatment of Marburg hemorrhagic fever can hamper the growth for the market up to some extent.
- Increasing government support for research in drug is expected to act as an opportunity for the market growth.
Scope of the report:
The report on Marburg hemorrhagic fever drug market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
| Attributes | Details |
| Report Title | Marburg Hemorrhagic Fever Drug Market - Global Industry Analysis, Growth, Size, Share, Trends And Forecast |
| Base Year | 2020 |
| Historic Data | 2018 & 2019 |
| Forecast Period | 2021–2028 |
| Segmentation | Types (Marburg Vaccine, AVI-7288, TKM-Marburg, and Others) Application (Clinics, Hospitals, Others) |
| Regional Scope | Asia Pacific, North America, Europe, Latin America, and Middle East & Africa |
| Report Coverage | Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast |
| Key Players Covered in the Report | GlaxoSmithKline plc, Arbutus Biopharma, Sarepta Therapeutics, Integrated BioTherapeutics, Inc. |
Marburg Hemorrhagic Fever Drug Market Segment Insights:
AVI- 7288 segment is projected to hold significant market share
In the terms of types, the market can be divided into Marburg vaccine, AVI-7288, TKM-Marburg, and Others. The AVI -7288 segment held a considerable share of the market in 2020. AVI-7288 is a positive-charged phosphorodiamidate morpholino oligomer that targets the viral messenger RNA that encodes the Marburg virus nucleoprotein. Its safety in humans has not been established. AVI-7288 has huge potential as a post exposure prophylactic for MARV infection in humans based on efficacy in nonhuman primates and pharmacokinetic studies in humans.
Hospital segment held substantial market share in 2020
Based on applications, the Marburg hemorrhagic fever drug market can be fragmented into clinics, hospitals, and others. The hospitals segment constituted a significant market share in 2020 and is projected to expand at a rapid rate during the forecast period. Treatment for Marburg hemorrhagic fever includes supportive hospital therapy, which includes balancing fluids and electrolytes, maintaining oxygen status and blood pressure, replacing lost blood and clotting components, and treating any aggravating infections.
North America dominates the global market
In terms of regions, the global market can be segregated into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The increased investment in healthcare and presence of global market players in North America is expected to drive the growth for the market in the region over the forecast period. Moreover, increasing awareness regarding chronic diseases can boost the market during the forecast period.
Segments
Segments Covered in the Report
By Types
- Marburg Vaccine
- AVI-7288
- TKM-Marburg
- Others
By Applications
- Clinics
- Hospitals
- Others
By Regions
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East & Africa
By Key Players
- GlaxoSmithKline plc
- Arbutus Biopharma
- Sarepta Therapeutics
- Integrated BioTherapeutics, Inc
Competitive Landscape
Key players in the Marburg hemorrhagic fever drug market include GlaxoSmithKline plc, Arbutus Biopharma, Sarepta Therapeutics, Integrated BioTherapeutics, Inc. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Marburg Hemorrhagic Fever Drug Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Marburg Hemorrhagic Fever Drug Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Marburg Hemorrhagic Fever Drug Market - Supply Chain
4.5. Global Marburg Hemorrhagic Fever Drug Market Forecast
4.5.1. Marburg Hemorrhagic Fever Drug Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Marburg Hemorrhagic Fever Drug Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Marburg Hemorrhagic Fever Drug Market Absolute $ Opportunity
5. Global Marburg Hemorrhagic Fever Drug Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Types
5.3.1. Marburg Vaccine
5.3.2. AVI-7288
5.3.3. TKM-Marburg
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Marburg Hemorrhagic Fever Drug Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Marburg Hemorrhagic Fever Drug Demand Share Forecast, 2019-2026
7. North America Marburg Hemorrhagic Fever Drug Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Types
7.4.1. Marburg Vaccine
7.4.2. AVI-7288
7.4.3. TKM-Marburg
7.4.4. Others
7.5. Basis Point Share (BPS) Analysis by Types
7.6. Y-o-Y Growth Projections by Types
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Marburg Hemorrhagic Fever Drug Demand Share Forecast, 2019-2026
8. Latin America Marburg Hemorrhagic Fever Drug Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Types
8.4.1. Marburg Vaccine
8.4.2. AVI-7288
8.4.3. TKM-Marburg
8.4.4. Others
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Marburg Hemorrhagic Fever Drug Demand Share Forecast, 2019-2026
9. Europe Marburg Hemorrhagic Fever Drug Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Types
9.4.1. Marburg Vaccine
9.4.2. AVI-7288
9.4.3. TKM-Marburg
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Marburg Hemorrhagic Fever Drug Demand Share Forecast, 2019-2026
10. Asia Pacific Marburg Hemorrhagic Fever Drug Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Types
10.4.1. Marburg Vaccine
10.4.2. AVI-7288
10.4.3. TKM-Marburg
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Marburg Hemorrhagic Fever Drug Demand Share Forecast, 2019-2026
11. Middle East & Africa Marburg Hemorrhagic Fever Drug Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Types
11.4.1. Marburg Vaccine
11.4.2. AVI-7288
11.4.3. TKM-Marburg
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Marburg Hemorrhagic Fever Drug Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Marburg Hemorrhagic Fever Drug Market: Market Share Analysis
12.2. Marburg Hemorrhagic Fever Drug Distributors and Customers
12.3. Marburg Hemorrhagic Fever Drug Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. GlaxoSmithKline plc
12.4.2. Arbutus Biopharma
12.4.3. Sarepta Therapeutics
12.4.4. Integrated BioTherapeutics, Inc
Segments Covered in the Report
By Types
- Marburg Vaccine
- AVI-7288
- TKM-Marburg
- Others
By Applications
- Clinics
- Hospitals
- Others
By Regions
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East & Africa
By Key Players
- GlaxoSmithKline plc
- Arbutus Biopharma
- Sarepta Therapeutics
- Integrated BioTherapeutics, Inc
Key players in the Marburg hemorrhagic fever drug market include GlaxoSmithKline plc, Arbutus Biopharma, Sarepta Therapeutics, Integrated BioTherapeutics, Inc. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.
Our Clients
Related Reports
Some other reports from this category!
